Yuyun Lusiyani
By the end of 2020, Kentucky’s newly elected Gov. Andy Beshear had one goal above all others: Keep people alive. The state was battling two merciless threats. COVID-19 was killing hundreds of people each month, and deadly drug overdoses were among the highest in the nation. Calling addiction a disease that breeds in isolation, Beshear worried people would stop seeking treatment for fear of contracting COVID-19. In a dramatic move aimed at expanding access to life-saving care during an unprecedented public health crisis, Governor Beshear’s administration made a pivotal decision that would profoundly reshape the state’s approach to substance abuse treatment and ignite a fierce debate over fiscal responsibility versus humanitarian imperative. This policy, designed to eliminate barriers to care, ultimately led to a staggering surge in Medicaid spending, a raft of warnings about potential fraud and subpar services, and eventually, federal investigations and a multi-million dollar settlement against the state’s largest treatment provider.
The Genesis of a Policy: Crisis and Compassion
Kentucky, nestled in the heart of Appalachia, has long been at the epicenter of the nation’s opioid epidemic. By 2020, the crisis was exacerbated by the COVID-19 pandemic, which brought with it widespread isolation, economic hardship, and disruptions to traditional healthcare access. Overdose deaths in the state were climbing at an alarming rate, and the healthcare system was strained by the dual pressures of infectious disease and a relentless addiction scourge. In response to this dire situation, Governor Beshear’s administration took decisive action. Understanding that existing bureaucratic hurdles could deter individuals from seeking immediate treatment, Kentucky joined more than 40 other states in temporarily lifting certain restrictions on Medicaid. Crucially, this included suspending "prior authorization" requirements for substance abuse treatment. Prior authorization is a mechanism where healthcare providers must obtain approval from a patient’s insurance company (in this case, state Medicaid insurers) before providing certain services, especially expensive or long-term treatments. It is designed to ensure that care is medically necessary, appropriate, and cost-effective, thereby acting as a crucial safeguard against waste and fraud. Beshear’s intent was clear: to remove any obstacle that might prevent a Kentuckian from accessing potentially life-saving addiction treatment, fearing that the isolation of the pandemic would push more people away from help.
A Flood of Funding: Unprecedented Access and Soaring Costs
The immediate effect of loosening these Medicaid controls was a dramatic increase in access to addiction treatment services across the Commonwealth. By 2023, as the COVID-19 pandemic began to wane and many states reinstated their prior authorization requirements, Kentucky notably chose to "stay the course." This decision set Kentucky apart, allowing treatment centers to continue offering a broad range of services without the stringent pre-approval process that other states deemed necessary. The result was a remarkable expansion of treatment capacity: that year, providers offered more than 1,100 spots for people seeking long-term residential treatment, a state record and, significantly, more slots per capita than any other state in the nation, according to a report from East Tennessee State University. This expansion was championed by the administration as a direct success of their policy, a testament to their commitment to making treatment readily available.
However, the unprecedented access came with an equally unprecedented price tag. The Medicaid bills for this extensive treatment began to pile up at an alarming rate. What was initially hailed as a humanitarian success soon drew the attention of financial watchdogs and industry experts. By February 2025, Kentucky Medicaid Commissioner Lisa Lee revealed that the previous year’s spending on behavioral health and addiction treatment had reached an unprecedented $2.3 billion. This represented a substantial increase from pre-pandemic levels, raising serious questions about the sustainability and oversight of the state’s program.
Warnings on the Horizon: A Chorus of Concern
As early as 2023, and intensifying throughout 2024, a chorus of warnings began to emerge from various corners of the healthcare industry. Experts, Medicaid insurers, and even local officials expressed growing concern that the absence of prior authorization was creating an environment ripe for abuse. Stuart Owen, an executive with a Kentucky Medicaid insurer, articulated this apprehension months before the spending figures were publicly announced, telling a state advisory committee that much of the skyrocketing expenditure was driven by the drug treatment industry, including "unscrupulous providers who are exploiting the heck out of that for money."
In August 2024, the Kentucky Association of Health Plans (KAHP), which represents the state’s Medicaid insurers, sent a scathing letter to the state Cabinet for Health and Family Services. The letter explicitly warned that weak oversight had led to "unnecessary" spending on treatment and, more critically, that the services treatment centers were billing the most for were not demonstrably leading to better health outcomes for patients. They highlighted concerns about providers overbilling for services not based on evidence or provided by licensed doctors or therapists. Part of their proposed solution was the immediate reinstatement of prior authorization. Tom Stephens, president of KAHP, later clarified that this letter was "simply one example of concerns that had been raised over time," indicating a persistent pattern of ignored warnings.
The concerns were not limited to insurance industry insiders. In September 2024, Somerset Mayor Alan Keck, whose rural southeastern Kentucky county had been devastated by opioids, penned a letter to the Beshear administration. Keck detailed alarming trends in his region, including treatment centers allegedly recruiting patients from out of state and using company addresses to establish fraudulent residency to bill Kentucky Medicaid. He also cited instances of companies misrepresenting the services they provided. "Our communities are seeing an influx of sober living facilities that are taking advantage of Kentucky’s Medicaid system and the lax requirements that linger from the Covid-19 pandemic," Keck wrote to then-health Secretary Eric Friedlander. Keck, who had unsuccessfully run in the 2023 Republican primary for governor, later expressed his belief that the administration "should’ve done more to rein in the drug treatment industry’s explosive growth."
Despite these explicit warnings from multiple stakeholders, the Beshear administration’s response was perceived by critics as insufficient. While Beshear’s spokesperson, Scottie Ellis, acknowledged that the governor "monitored the concerns expressed publicly and those shared with his administration" and that the state health agency worked with Medicaid insurers, she declined to specify what concrete measures were taken during this critical period.
The Scrutiny Intensifies: The Case of Addiction Recovery Care (ARC)
At the heart of the burgeoning scandal was Addiction Recovery Care (ARC), a massive treatment provider that had become Kentucky’s largest recipient of state funds for addiction services between 2019 and 2025. ARC, at its peak, treated approximately one-third of all Kentuckians seeking drug treatment in the state. Investigative reporting by the Lexington Herald-Leader, in partnership with ProPublica, published in spring 2025, brought the allegations against ARC into sharp public focus. The investigation detailed how ARC allegedly exploited Kentucky’s loosened spending controls and potentially engaged in falsified billing practices.
State data revealed that more than half of the services ARC billed for were "lower-level services" – primarily peer support groups and psychoeducation – rather than those directly provided by licensed doctors or therapists. Medicaid experts had specifically warned that these types of services were particularly susceptible to abuse without adequate oversight. For instance, Kentucky Medicaid paid over $147 million for peer support services in 2023 and 2024. Payments for psychoeducation, which is typically a component of a regular clinician-patient appointment, jumped from $40.4 million to over $168 million in the same period, with most of this money going to ARC. Medicaid insurers noted that Kentucky was one of the only states that allowed psychoeducation to be billed for separately, making it an easy target for overbilling. Shelby Steuart, a health policy professor at the University of Maryland, succinctly summarized the situation: "It just became an opportunity for people to make money."
Federal Intervention and Legal Repercussions
The concerns escalated from warnings to formal investigations. The Federal Bureau of Investigation (FBI) had been investigating ARC for two years prior to the public revelations. The company’s troubles intensified significantly when, "this week" (as per the original article’s framing), the Department of Justice (DOJ) announced it had reached a $16 million settlement with ARC over Medicaid fraud allegations. These allegations stemmed from a 2023 whistleblower lawsuit filed by three former ARC employees, who claimed the company directed employees to falsely bill Medicaid for services like peer support. While the settlement resolved these allegations without a determination of liability, it underscored the severity of the alleged misconduct.
Adding to ARC’s woes, "last month," the DOJ separately indicted ARC’s founder, Tim Robinson, for wire fraud and money laundering related to an alleged scheme to defraud multiple lenders. Robinson has pleaded not guilty to these charges. Despite the mounting legal pressure, ARC maintained its innocence, stating in April that it "has never knowingly or fraudulently billed Medicaid for services, and there is no evidence that the organization encouraged employees to falsify group notes for billing purposes."
The fallout from these investigations and allegations has already had a significant impact on Kentucky’s addiction treatment landscape. ARC has been forced to close most of its facilities over the past two years, resulting in a staggering 56% decrease in long-term residential treatment beds statewide, according to the most recent available data. This drastic reduction raises new concerns about access to care, even as the state grapples with the financial consequences of its earlier policies.
Beshear’s Defense: Lives Over Dollars
Throughout the escalating controversy, Governor Beshear has remained unapologetic about his administration’s approach to Medicaid spending on drug treatment. In an interview in early June with ProPublica and the Lexington Herald-Leader, he pointed directly to the continued decline in drug overdose deaths as irrefutable proof that his decision not to reinstate prior authorization sooner was the correct one. He argued that forcing treatment centers to prove medical necessity for costly recovery services would have created barriers and delays, leading to more fatalities.
"If we’d gone back in time too early and changed things too drastically, how many more people would have died that we’ve saved? With four straight years of drug overdose decreases, they can throw blame at me," Beshear stated. "We’ll talk about dollars, but there are people’s kids that are still alive today because they were able to get addiction treatment services and get them quickly." His spokesperson, Scottie Ellis, reiterated this stance, emphasizing that "actions taken by Gov. Beshear and his administration have decreased overdose deaths for four straight years," and that the policies should be measured by lives saved.
Beshear acknowledged in the June interview that his administration’s health agency "was probably taking too long" to enact some spending guardrails by the time the Republican-controlled legislature acted in July 2025. However, he consistently denied that his 2020 order directly led to a rise in Medicaid fraud or abuse.
A Broader Perspective: Deciphering the Decline in Overdoses
While Kentucky’s overdose deaths did decline significantly between 2020 and 2025, experts caution against solely attributing this trend to the state’s loosened Medicaid rules. Data from the Kaiser Family Foundation (KFF) and the Centers for Disease Control and Prevention (CDC) indicate that the drop in overdose fatalities was not unique to Kentucky. Other states severely impacted by the opioid epidemic, including those that did not loosen Medicaid billing rules like Tennessee and West Virginia, also experienced year-over-year decreases in fatal overdoses during the same period.
Academic studies and public health analyses mostly agree that the national decline in the death rate had more to do with several broader factors: a decline in opioid prescriptions, a significant increase in the availability and use of the overdose-reversing drug naloxone, and, paradoxically, less fentanyl in the illicit drug supply in some regions at certain times. Medicaid and behavioral health experts in Kentucky themselves stated in state hearings that some of the services drug treatment companies billed the most for – such as peer support and psychoeducation – were not directly associated with a decline in overdose deaths. This broader context suggests that while increased access to treatment may have played a role, it was likely one of several contributing factors, and perhaps not the primary driver, behind Kentucky’s declining overdose rates.
Political Showdown and Policy Reversal
The Beshear administration’s stance and the mounting evidence of financial irregularities ignited a fierce political battle with the state’s Republican-controlled legislature. Republicans accused Beshear of gross mismanagement of the state’s Medicaid program, asserting that the administration had been "willfully ignorant, derelict in their duties, or complicit." Senator Chris McDaniel, a prominent Republican legislator, championed a bill during the 2025 legislative session designed to rein in spending.
The bill sought to reinstate prior authorization requirements for addiction treatment services and, significantly, revoked the governor’s power to unilaterally make changes to Kentucky Medicaid without legislative permission. Beshear vetoed the bill, arguing that it "will put up barriers to and delay healthcare for Kentuckians." However, the Republican-majority legislature swiftly overrode his veto, citing the rampant waste, fraud, and abuse that had characterized the preceding years. This legislative override marked a definitive end to Kentucky’s era of unchecked Medicaid spending on addiction treatment.
Lingering Impacts and the Future of Treatment
The saga of Kentucky’s Medicaid expansion for addiction treatment leaves a complex legacy. On one hand, Governor Beshear’s administration undeniably facilitated unprecedented access to care during a critical period, potentially saving lives. On the other hand, the cost has been immense, both financially and in terms of public trust, culminating in federal investigations and the indictment of a major provider’s leader. The estimated $2.3 billion spent, the $16 million settlement, and the ongoing legal battles underscore the financial burden placed on state coffers.
The closure of most of ARC’s facilities, leading to a 56% reduction in residential treatment beds, presents a new challenge for the state. While it addresses the source of much of the alleged fraud, it also impacts the overall capacity for treatment, forcing the state to re-evaluate how it will meet the ongoing demand for addiction services. The experience highlights the perennial tension between rapid access to care, essential in public health emergencies, and the necessity of robust oversight to prevent fraud and ensure quality. As Kentucky moves forward under reinstated spending controls, the lessons learned from this costly experiment will undoubtedly shape the future of addiction treatment policy, emphasizing the critical balance required to save lives responsibly and sustainably. The state now faces the arduous task of rebuilding trust in its Medicaid system while ensuring that genuine care remains accessible to those who desperately need it.
Joko Widodo
admin
Nila Kartika Wati
Pevita Pearce
Nana Wu